Anteilseigner
OrbiMed Advisors Private Equity (11,78 %) Vivo Capital LLC (9,65 %) Deep Track Capital LP (9,44 %) Millennium Management LLC (5,31 %) Venrock Associates (5,27 %) BlackRock Fund Advisors (4,57 %) LAV Management Co., Ltd. (4,49 %) Citadel Advisors LLC (4,30 %) Fidelity Management & Research Co. LLC (4,27 %) Franklin Advisers, Inc. (3,68 %) Point72 Asset Management LP (3,44 %) The Vanguard Group, Inc. (3,26 %) Fairmount Funds Management LLC (3,16 %) Janus Henderson Investors US LLC (3,05 %) Deerfield Management Co. LP (2,88 %) Suvretta Capital Management LLC (2,11 %) Great Point Partners LLC (2,03 %) Schonfeld Strategic Advisors LLC (1,85 %) Driehaus Capital Management LLC (1,68 %)
Kontakt
Terns Pharmaceuticals Inc.